Ivermectin prophylactic study from India
Ivermectin in India, Prophylactic role of ivermectin in SARS-CoV-2 infection among healthcare workers
https://www.aiims.edu/en.html
https://assets.researchsquare.com/files/rs-208785/v1/d6ff79a3-d354-4aba-a6b0-4bc123bbd225.pdf
https://www.researchsquare.com/article/rs-208785/v1
Background
Healthcare workers (HCWs) are vulnerable to getting infected withSARS-CoV-2
Preventing HCWs from getting infected is a priority to maintain healthcare services
The therapeutic and preventive role of ivermectin in COVID-19 is being investigated
Based on promising results of in vitro studies of oral ivermectin,
this study to look at prophylactic role of oral ivermectin
Methods
Prospective cohort study was conducted at AIIMS Bhubaneswar
Two-doses of oral ivermectin, 300 μg/kg at a gap of 72 hours
Primary outcome, COVID-19 infection in the month following
Of 3892 employees,
3532 (90.8%) participated in the study
Ivermectin uptake n = 2, 384 (67.5%)
Non uptake, n = 1147 (32.5%)
Results
Development of symptomatic infection
331 participants, developed symptoms
131 in takers
200 from non takers
Ivermectin takers, 6%
Non takers, 15%
Testing positive, 201
Ivermectin takers, 2%
Non takers, 11.7%
Implications for transmission
HCWs who had taken two-doses
(Single dose did not reach significance)
Significantly lower risk of contracting COVID-19 disease during the following month was 0.18
Adjusted Relative Risk 0.17
1.8% reported adverse events, mild and self-limiting
Conclusion and relevance
Two-doses of oral ivermectin (300 μg/kg given 72 hours apart) as chemoprophylaxis among HCWs
reduces the risk of COVID-19 infection by 83% in the following month.
Safe, effective, and low-cost chemoprophylaxis have relevance in the containment of pandemic
alongside vaccine.
https://www.pharmaceutical-technology.com/news/aiims-study-covid-19/
AIIMS Director, Gitanjali Batmanabane
Earlier, at least 20 to 25 HCWs were getting infected with the virus daily.
After the workers started taking ivermectin, the number of infection has come down to one or two per day
Critique
The safety of the drug has been established by its large-scale use in the last four decades for
various indications such as onchocerciasis, scabies, head lice, and other parasitic infestations
https://www.facebook.com/john.l.campbell1/
https://healthfeedback.org/claimreview/ivermectin-isnt-a-highly-effective-drug-for-treating-covid-19-tess-lawrie/?fbclid=IwAR2ahWjmOXuMx2u6FKgF9wTCESwHtN9EXKiKsTWCOoAygBb_P5thfAyOilA
Видео Ivermectin prophylactic study from India канала Dr. John Campbell
https://www.aiims.edu/en.html
https://assets.researchsquare.com/files/rs-208785/v1/d6ff79a3-d354-4aba-a6b0-4bc123bbd225.pdf
https://www.researchsquare.com/article/rs-208785/v1
Background
Healthcare workers (HCWs) are vulnerable to getting infected withSARS-CoV-2
Preventing HCWs from getting infected is a priority to maintain healthcare services
The therapeutic and preventive role of ivermectin in COVID-19 is being investigated
Based on promising results of in vitro studies of oral ivermectin,
this study to look at prophylactic role of oral ivermectin
Methods
Prospective cohort study was conducted at AIIMS Bhubaneswar
Two-doses of oral ivermectin, 300 μg/kg at a gap of 72 hours
Primary outcome, COVID-19 infection in the month following
Of 3892 employees,
3532 (90.8%) participated in the study
Ivermectin uptake n = 2, 384 (67.5%)
Non uptake, n = 1147 (32.5%)
Results
Development of symptomatic infection
331 participants, developed symptoms
131 in takers
200 from non takers
Ivermectin takers, 6%
Non takers, 15%
Testing positive, 201
Ivermectin takers, 2%
Non takers, 11.7%
Implications for transmission
HCWs who had taken two-doses
(Single dose did not reach significance)
Significantly lower risk of contracting COVID-19 disease during the following month was 0.18
Adjusted Relative Risk 0.17
1.8% reported adverse events, mild and self-limiting
Conclusion and relevance
Two-doses of oral ivermectin (300 μg/kg given 72 hours apart) as chemoprophylaxis among HCWs
reduces the risk of COVID-19 infection by 83% in the following month.
Safe, effective, and low-cost chemoprophylaxis have relevance in the containment of pandemic
alongside vaccine.
https://www.pharmaceutical-technology.com/news/aiims-study-covid-19/
AIIMS Director, Gitanjali Batmanabane
Earlier, at least 20 to 25 HCWs were getting infected with the virus daily.
After the workers started taking ivermectin, the number of infection has come down to one or two per day
Critique
The safety of the drug has been established by its large-scale use in the last four decades for
various indications such as onchocerciasis, scabies, head lice, and other parasitic infestations
https://www.facebook.com/john.l.campbell1/
https://healthfeedback.org/claimreview/ivermectin-isnt-a-highly-effective-drug-for-treating-covid-19-tess-lawrie/?fbclid=IwAR2ahWjmOXuMx2u6FKgF9wTCESwHtN9EXKiKsTWCOoAygBb_P5thfAyOilA
Видео Ivermectin prophylactic study from India канала Dr. John Campbell
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
India variant increases in UKNepal sees explosion in COVID-19 cases | DW NewsPost vaccine myocarditisLessons from the Zimbabwe Ivermectin experienceWhy I HAVEN'T yet taken the COVID VACCINEWhat Is Mucormycosis Or Black Fungus That Can Cause Blindness or Even Death After Covid-19The Vaccine: India's COVID-19 death toll grows at an alarming speed | ABC NewsDr Pierre Kory, Part 1, Steroids and anticoagulantsVitamin D deficiency in IndiaIvermectin Dose For COVID (Prophylaxis, Acute Disease, Long Haulers)Ben Carson warns Americans this will cause 'irreparable damage'Gravitas: Here are India's 4 strategic moves in 14 daysUK is 'witnessing a working-class revolt against the Labour Party'Heart inflammation in IsraelIndian variant now in USWhich is the Best Vaccine? Covaxin vs Covishield | Dhruv Rathee'Absolutely not true': Dr. Gupta reacts to Fox host's vaccine commentsGravitas | Covid Vaccine Patents: Big win for India at the World Trade OrganisationGravitas: Survey pegs the U.S as a bigger threat than China & RussiaThe impact of Ivermectin use in Zimbabwe